Evaluation of Merbarone in Malignant Melanoma, Phase II

Closed

Phase

Accrual

100%

Published

Abbreviated Title

Evaluation of Merbarone in Malignant Melanoma, Phase II

Activated

09/01/1991

Closed

06/15/1993

Publication Information Expand/Collapse

2008

Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials. [PMID18235113]

EL Korn;PY Liu;SJ Lee;JAW Chapman;D Niedzwiecki;VJ Suman;J Moon;VK Sondak;MB Atkins;EA Eisenhauer;W Parulekar;SN Markovic;S Saxman;JM Kirkwood Journal of Clinical Oncology 26(4):527-534

2001

Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials

JM Unger;LE Flaherty;PY Liu;KS Albain;VK Sondak Cancer 91(6):148-1155

1995

Evaluation of merbarone (NSC 336628) in disseminated malignant melanoma: A Southwest Oncology Group study.

M Slavik;PY Liu;EH Kraut;RB Natale;LE Faherty;VK Sondak Investigational New Drugs 13:143-147

1994

Phase II evaluation of merbarone in disseminated malignant melanoma: A Southwest Oncology Group study.

M Slavik;PY Liu;E Kraut;R Natale;V Sondak ASCO 13:398(#1357)